Back to Press Releases
Acquisition

Aethon Capital Completes Acquisition of MedTech Solutions for $2.3 Billion

Share

Aethon Capital today announced the completion of its acquisition of MedTech Solutions, Inc. ("MedTech" or the "Company"), a leading provider of healthcare technology platforms serving over 4,500 hospitals and health systems across the United States, in a transaction valued at approximately $2.3 billion.

MedTech Solutions is the market leader in integrated clinical workflow management software, connecting healthcare providers with real-time patient data, analytics, and operational tools that improve care quality while reducing administrative costs. The Company's platform processes over 2.8 billion transactions annually and serves approximately 35% of U.S. acute care hospitals.

"MedTech Solutions represents exactly the type of investment Aethon seeks—a mission-critical technology platform with strong recurring revenues, deep competitive moats, and significant runway for organic and inorganic growth," said David Chen, Managing Partner. "We look forward to partnering with the management team to accelerate the Company's growth trajectory."

Under Aethon's ownership, MedTech Solutions plans to invest significantly in product innovation, expand its international footprint, and pursue strategic acquisitions to broaden its platform capabilities.

MedTech CEO Sarah Williams commented: "Aethon's deep healthcare expertise and track record of building technology companies make them the ideal partner for our next phase of growth. Their operational resources and strategic vision will enable us to better serve our hospital clients and their patients."

The acquisition was funded through a combination of equity from Aethon Capital Partners IX and committed debt financing.

This press release contains forward-looking statements that are subject to risks and uncertainties. Actual results may differ materially from those projected. This does not constitute an offer to sell or solicitation of an offer to buy any securities.